Skip to content
← Full study record

NCT00354835 · OUTCOME

Compare Event Free Survival (EFS) With Respect to the Level of % Change in FDG PET Maximum Standard Uptake Value (SUVmax) at Week 4

Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma · Source last updated 2023-01-31

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
Probability
Interval / dispersion
95% Confidence Interval
Time frame
4 years

What was measured

4-year EFS (probability of no relapse, secondary malignancy, or death after 4 years in the study).

Analysis population: 452 participants were excluded due to ineligibility or absence of SUVmax evaluation at baseline and week 4.

Groups in this outcome

% Change in SUVmax From Baseline to Week 4 < 40%

Not reported

% Change in SUVmax From Baseline to Week 4 >= 40%

Not reported

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
% Change in SUVmax From Baseline to Week 4 < 40%7
% Change in SUVmax From Baseline to Week 4 >= 40%22

Reported measurements

Source class 1
Values in Probability · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
% Change in SUVmax From Baseline to Week 4 < 40%0.2857Not reported0.00000.6204Not reported
% Change in SUVmax From Baseline to Week 4 >= 40%0.6364Not reported0.43540.8374Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        0.0000
        upper Limit
        0.6204
        value
        0.2857
      2. group Id
        OG001
        lower Limit
        0.4354
        upper Limit
        0.8374
        value
        0.6364
denoms
  1. counts
    1. group Id
      OG000
      value
      7
    2. group Id
      OG001
      value
      22
    units
    Participants
description
4-year EFS (probability of no relapse, secondary malignancy, or death after 4 years in the study).
dispersion Type
95% Confidence Interval
groups
  1. id
    OG000
    title
    % Change in SUVmax From Baseline to Week 4 < 40%
  2. id
    OG001
    title
    % Change in SUVmax From Baseline to Week 4 >= 40%
param Type
NUMBER
population Description
452 participants were excluded due to ineligibility or absence of SUVmax evaluation at baseline and week 4.
reporting Status
POSTED
time Frame
4 years
title
Compare Event Free Survival (EFS) With Respect to the Level of % Change in FDG PET Maximum Standard Uptake Value (SUVmax) at Week 4
type
SECONDARY
unit Of Measure
Probability

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice